Diffuse infiltrative lymphocytosis syndrome

Last updated
Diffuse infiltrative lymphocytosis syndrome
Specialty Immunology
Symptoms Parotitis, cervical lymphadenopathy, dry eyes, dry mouth
Diagnostic method Based on symptoms, confirmation of HIV infection (serology), confirmation of organ infiltration by CD8+ T cells (tissue biopsy), and exclusion of other autoimmune conditions
Differential diagnosis Primary Sjogren's Syndrome, IgG4-related disease, chronic hepatitis C infection, chronic HTLV1 infection, chronic graft versus host disease, and immune reconstitution inflammatory syndrome
TreatmentHighly active antiretroviral therapy (HAART) and as-needed steroids

Diffuse infiltrative lymphocytosis syndrome (DILS) is a rare multi-system complication of HIV believed to occur secondary to an abnormal persistence of the initial CD8+ T cell expansion that regularly occurs in an HIV infection. [1] This persistent CD8+ T cell expansion occurs in the setting of a low CD4+/CD8+ T cell ratio and ultimately invades and destroys tissues and organs resulting in the various complications of DILS. [1] [2] [3] [4] [5] DILS classically presents with bilateral salivary gland enlargement (parotitis), cervical lymphadenopathy, and sicca symptoms such as xerophthalmia (dry eyes) and xerostomia (dry mouth), but it may also involve the lungs, nervous system, kidneys, liver, digestive tract, and muscles. [1] [2] [3] [4] [5] Once suspected, current diagnostic workups include (1) confirming HIV infection, (2) confirming six or greater months of characteristic signs and symptoms, (3) confirming organ infiltration by CD8+ T cells, and (4) exclusion of other autoimmune conditions. [1] [3] [4] Once the diagnosis of DILS is confirmed, management includes highly active antiretroviral therapy (HAART) and as-needed steroids. [1] [4] [5] With proper treatment, the overall prognosis of DILS is favorable. [1] [2] [4]

Contents

Signs and Symptoms

The most common clinical features of DILS are bilateral salivary gland enlargement (parotitis), cervical lymphadenopathy, and sicca symptoms such as dry eyes and dry mouth. [1] [2] [3] [4] Although the swelling of the salivary glands is classically bilateral, it can present unilaterally as well. [1] Although less common than glandular features, extraglandular characteristics can present in DILS and affect the lungs, nervous system, kidneys, liver, digestive tract, and muscles. [1] [2] [3] [4] [5]

For lung involvement, the classic presentation is lymphocytic interstitial pneumonia which may be asymptomatic or present with fever, weight loss, chronic dry cough, or progressive exertional dyspnea (shortness of breath). [1] [3] [4] [5] On physical exam, a physician may note clubbing or crackles on pulmonary auscultation. [1]

For nervous system involvement, potential complications include facial nerve palsy, aseptic meningitis, and peripheral neuropathy. [1] [3] [4]

For kidney involvement, the most common sequela is lymphocytic interstitial nephropathy which occurs in approximately 6%-8% of patients with DILS. The severity and presentation are varied but include acute kidney injury, renal tubular acidosis, mild proteinuria, hematuria (blood in the urine), or nephromegaly (kidney enlargement). [1] [3] [4]

For liver involvement, patients with DILS may develop hepatomegaly (enlarged liver) or lymphocytic hepatitis which can progress to liver failure with portal hypertension and ascites. [1] [3] [4]

For muscle involvement, those with DILS may develop DILS-associated myositis. [1] [4]

Cause

DILS occurs exclusively in HIV-positive patients, especially those with uncontrolled infections. [1] [2]

There is an association of DILS with HLA-DR5 as well as HLA-DRB1 alleles that express the ILEDE amino acid sequence such as HLA-DRB1*1102, HLA-DRB1*1301, and HLA-DRB1*1302. [1] [4] [5]

Pathophysiology

While the pathophysiology of DILS has not been fully determined, it is hypothesized that the initial CD8+ T cell expansion that normally occurs in an HIV infection abnormally persists in DILS and eventually leads to tissue and organ infiltration and destruction. [1] [2] [3] [4] [5] This infiltration is thought to occur due to the secretion of cytokines by HIV-infected monocytes that stimulate endothelial and ductal cells causing them to express proteins such as ICAM-1 which then induce the migration of CD8+ T cells. [1] [3]

Diagnosis

Patients with DILS will be HIV-positive and characteristically have CD8+T cell tissue and organ infiltration in the setting of a CD8+ T cell expansion with a low CD4+/CD8+ T cell ratio. [1] [2] [3] [5] Although a diagnostic workup has not been finalized, the suggested diagnostic workup includes (1) confirming HIV infection, (2) confirming six or greater months of characteristic signs and symptoms, (3) evidence of organ infiltration by CD8+ T cells, and (4) exclusion of other autoimmune conditions. [1] [3] [4] HIV infection can be confirmed with detection of viral load or positive HIV serology. [1] Labial salivary gland biopsy with immunohistochemistry is most commonly used to confirm organ infiltration by CD8+ T cells. [1] [2] [3] [4] It will usually demonstrate periductal CD8+ T cell infiltration with ductal atypia, acinar atrophy, fibrosis, and a focus score greater than or equal to one. [1] [2] Common tests to exclude autoimmune conditions include screening for complement activity, cryoglobulin levels, IgG4 and IgE levels, and levels of several autoantibodies including anti-nuclear antibody (ANA), SS-A (Ro), SS-B (La), and rheumatoid factor (RF). [1] [3] Additionally, other viral infections such as hepatitis C, Epstein–Barr virus, and HTLV-1 should be tested for and excluded. [1] [4]

Differential Diagnosis

The differential diagnosis of DILS includes primary Sjogren's Syndrome, IgG4-related disease, chronic hepatitis C infection, chronic HTLV1 infection, chronic graft versus host disease, and immune reconstitution inflammatory syndrome. [1] [2] [3] [4] [5]

Management

The gold standard treatment of DILS is highly active antiretroviral therapy (HAART). [1] [4] [5] Additionally, a short course of oral steroids may be used to quicken the improvement in symptomatic patients. [1] [4] For those with kidney or central nervous system involvement, an intravenous steroid may be used before an oral steroid. [1]

Prognosis

The overall prognosis of DILS is favorable as it is not commonly a cause of death and is associated with decreased rates of progression to AIDS, less opportunistic infections, and lower HIV disease stage when compared to HIV-positive patients without DILS. [1] [2] [4] Although treatment with HAART and steroids is commonly effective, DILS can persist or relapse despite appropriate management. [1]

Epidemiology

The estimated prevalence of DILS among those infected with HIV is approximately 3% to 7.8%. [1] [2] [3] [5] However, this may be an underestimation as the clinical presentation has evolved with the use of antiretrovirals and may no longer align with initial descriptions of its symptomatology. [1] Since the development and utilization of HAART, the incidence and prevalence of DILS have decreased. [1] [2] [3] [5]

Africa has the highest prevalence of DILS worldwide. [3] Black people are most commonly affected by DILS. [1] [3]

History

DILS was first discovered in 1985 when a subset of HIV-infected patients was noted to have enlargement of their lymph nodes and salivary glands. [3] However, it was not given the name of diffuse infiltrative lymphocytosis syndrome until 1989. [1] [3]

Related Research Articles

<span class="mw-page-title-main">Sjögren syndrome</span> Medical condition

Sjögren syndrome or Sjögren's syndrome is a long-term autoimmune disease that affects the body's moisture-producing glands, and often seriously affects other organ systems, such as the lungs, kidneys, and nervous system.

<span class="mw-page-title-main">Parotid gland</span> Major salivary gland in many animals

The parotid gland is a major salivary gland in many animals. In humans, the two parotid glands are present on either side of the mouth and in front of both ears. They are the largest of the salivary glands. Each parotid is wrapped around the mandibular ramus, and secretes serous saliva through the parotid duct into the mouth, to facilitate mastication and swallowing and to begin the digestion of starches. There are also two other types of salivary glands; they are submandibular and sublingual glands. Sometimes accessory parotid glands are found close to the main parotid glands.

This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition.

<span class="mw-page-title-main">Parotitis</span> Medical condition

Parotitis is an inflammation of one or both parotid glands, the major salivary glands located on either side of the face, in humans. The parotid gland is the salivary gland most commonly affected by inflammation.

Immune reconstitution inflammatory syndrome (IRIS) is a condition seen in some cases of HIV/AIDS or immunosuppression, in which the immune system begins to recover, but then responds to a previously acquired opportunistic infection with an overwhelming inflammatory response that paradoxically makes the symptoms of infection worse.

HIV-associated nephropathy (HIVAN) refers to kidney disease developing in association with infection by human immunodeficiency virus, the virus that causes AIDS. The most common, or "classical", type of HIV-associated nephropathy is a collapsing focal segmental glomerulosclerosis (FSGS), though other forms of kidney disease may also occur. Regardless of the underlying histology, kidney disease in HIV-positive patients is associated with an increased risk of death.

<span class="mw-page-title-main">Benign lymphoepithelial lesion</span> Medical condition

Benign lymphoepithelial lesion or Mikulicz' disease is a type of benign enlargement of the parotid and/or lacrimal glands. This pathologic state is sometimes, but not always, associated with Sjögren's syndrome.

A systemic disease is one that affects a number of organs and tissues, or affects the body as a whole.

<span class="mw-page-title-main">Sialadenitis</span> Medical condition

Sialadenitis (sialoadenitis) is inflammation of salivary glands, usually the major ones, the most common being the parotid gland, followed by submandibular and sublingual glands. It should not be confused with sialadenosis (sialosis) which is a non-inflammatory enlargement of the major salivary glands.

<span class="mw-page-title-main">Lymphocytic interstitial pneumonia</span> Medical condition

Lymphocytic interstitial pneumonia (LIP) is a syndrome secondary to autoimmune and other lymphoproliferative disorders. Symptoms include fever, cough, and shortness of breath. Lymphocytic interstitial pneumonia applies to disorders associated with both monoclonal or polyclonal gammopathy.

Drug rash with eosinophilia and systemic symptoms or drug reaction with eosinophilia and systemic symptoms (DRESS), also termed drug-induced hypersensitivity syndrome (DIHS), is a rare reaction to certain medications. It involves primarily a widespread skin rash, fever, swollen lymph nodes, and characteristic blood abnormalities such as an abnormally high level of eosinophils, low number of platelets, and increased number of atypical white blood cells (lymphocytes). However, DRESS is often complicated by potentially life-threatening inflammation of internal organs and the syndrome has about a 10% mortality rate. Treatment consists of stopping the offending medication and providing supportive care. Systemic corticosteroids are commonly used as well but no controlled clinical trials have assessed the efficacy of this treatment.

Oral and maxillofacial pathology refers to the diseases of the mouth, jaws and related structures such as salivary glands, temporomandibular joints, facial muscles and perioral skin. The mouth is an important organ with many different functions. It is also prone to a variety of medical and dental disorders.

<span class="mw-page-title-main">Marginal zone B-cell lymphoma</span> Group of lymphomas

Marginal zone B-cell lymphomas, also known as marginal zone lymphomas (MZLs), are a heterogeneous group of lymphomas that derive from the malignant transformation of marginal zone B-cells. Marginal zone B cells are innate lymphoid cells that normally function by rapidly mounting IgM antibody immune responses to antigens such as those presented by infectious agents and damaged tissues. They are lymphocytes of the B-cell line that originate and mature in secondary lymphoid follicles and then move to the marginal zones of mucosa-associated lymphoid tissue, the spleen, or lymph nodes. Mucosa-associated lymphoid tissue is a diffuse system of small concentrations of lymphoid tissue found in various submucosal membrane sites of the body such as the gastrointestinal tract, mouth, nasal cavity, pharynx, thyroid gland, breast, lung, salivary glands, eye, skin and the human spleen.

<span class="mw-page-title-main">Acute generalized exanthematous pustulosis</span> Medical condition

Acute generalized exanthematous pustulosis (AGEP) is a rare skin reaction that in 90% of cases is related to medication.

<span class="mw-page-title-main">Signs and symptoms of HIV/AIDS</span>

The stages of HIV infection are acute infection, latency, and AIDS. Acute infection lasts for several weeks and may include symptoms such as fever, swollen lymph nodes, inflammation of the throat, rash, muscle pain, malaise, and mouth and esophageal sores. The latency stage involves few or no symptoms and can last anywhere from two weeks to twenty years or more, depending on the individual. AIDS, the final stage of HIV infection, is defined by low CD4+ T cell counts, various opportunistic infections, cancers, and other conditions.

Chronic sclerosing sialadenitis is a chronic (long-lasting) inflammatory condition affecting the salivary gland. Relatively rare in occurrence, this condition is benign, but presents as hard, indurated and enlarged masses that are clinically indistinguishable from salivary gland neoplasms or tumors. It is now regarded as a manifestation of IgG4-related disease.

Heart problems are more common in people with HIV/AIDS. Those with left ventricular dysfunction have a median survival of 101 days as compared to 472 days in people with AIDS with healthy hearts. HIV is a major cause of cardiomyopathy. The most common type of HIV induced cardiomyopathy is dilated cardiomyopathy also known as eccentric ventricular hypertrophy which leads to impaired contraction of the ventricles due to volume overload. The annual incidence of HIV associated dilated cardiomyopathy was 15.9/1000 before the introduction of highly active antiretroviral therapy (HAART). However, in 2014, a study found that 17.6% of HIV patients have dilated cardiomyopathy (176/1000) meaning the incidence has greatly increased.

Human immunodeficiency virus salivary gland disease, is swelling of the salivary glands and/or xerostomia in individuals infected with human immunodeficiency virus.

Oral manifestations of systematic disease are signs and symptoms of disease occurring elsewhere in the body detected in the oral cavity and oral secretions. High blood sugar can be detected by sampling saliva. Saliva sampling may be a non-invasive way to detect changes in the gut microbiome and changes in systemic disease. Another example is tertiary syphilis, where changes to teeth can occur. Syphilis infection can be associated with longitudinal furrows of the tongue.

<span class="mw-page-title-main">Bictegravir/emtricitabine/tenofovir alafenamide</span> Fixed dose combination HIV drug

Bictegravir/emtricitabine/tenofovir alafenamide, sold under the brand name Biktarvy, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. One tablet, taken orally once daily, contains 50 mg bictegravir, 200 mg emtricitabine, and 25 mg tenofovir alafenamide. It was approved for use in the United States in February 2018, and for use in the European Union in June 2018.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Ghrenassia, Etienne; Martis, Nihal; Boyer, Julien; Burel-Vandenbos, Fanny; Mekinian, Arsène; Coppo, Paul (2015-05-01). "The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review". Journal of Autoimmunity. 59: 19–25. doi:10.1016/j.jaut.2015.01.010. ISSN   0896-8411.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Meer S. (2019). Human immunodeficiency virus and salivary gland pathology: an update. Oral surgery, oral medicine, oral pathology and oral radiology, 128(1), 52–59. https://doi.org/10.1016/j.oooo.2019.01.001. PMID 30827854.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Nizamuddin, Imran; Koulen, Peter; McArthur, Carole P. (2018-09-13). "Contribution of HIV Infection, AIDS, and Antiretroviral Therapy to Exocrine Pathogenesis in Salivary and Lacrimal Glands". International Journal of Molecular Sciences. 19 (9): 2747. doi:10.3390/ijms19092747. ISSN   1422-0067. PMC   6164028 . PMID   30217034.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Reveille, John D.; Williams, Francis M. (2006-12-01). "Rheumatologic complications of HIV infection". Best Practice & Research Clinical Rheumatology. Infection and Musculoskeletal Conditions. 20 (6): 1159–1179. doi:10.1016/j.berh.2006.08.015. ISSN   1521-6942.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 Walker, U. A.; Tyndall, A.; Daikeler, T. (2008-04-25). "Rheumatic conditions in human immunodeficiency virus infection". Rheumatology. 47 (7): 952–959. doi:10.1093/rheumatology/ken132. ISSN   1462-0324.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.